Client News

MagForce AG Publishes Financial Results for the Year 2020 and Operative Highlights

Adocia initiates BC LisPram Phase 1 Clinical Trial in Pump for People with Type 1 Diabetes

Imcyse announces appointment of new Scientific Advisory Board and opening of new headquarters to prepare for next phase of growth

Abivax reports excellent phase 2a clinical safety and efficacy results with 50mg ABX464 in rheumatoid arthritis

InflaRx to Present at the Raymond James Human Health Innovation Conference

Avisa Diagnostics to Participate in Renmark’s Virtual Non-Deal Roadshow Series on June 17, 2021

ADOCIA Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 81st Scientific Sessions

InflaRx Doses First Patient in Multicenter Phase II Clinical Trial in Cutaneous Squamous Cell Carcinoma with Vilobelimab

Avisa Diagnostics Appoints Barbara Bunger, PhD as Vice President, Clinical Development

ADOCIA presents clinical results on M1Pram at the 14th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2021)